Manifesto for a European anxiety disorders research network

Eur Neuropsychopharmacol. 2010 Jun;20(6):426-32. doi: 10.1016/j.euroneuro.2010.02.015. Epub 2010 Mar 30.


Despite the size, burden and costs of anxiety disorders, many patients remain unrecognised, and the effectiveness of evidence-based interventions in routine clinical practice can be disappointing. The European College of Neuropsychopharmacology (ECNP) has established the ECNP Network Initiative (ECNP-NI) to help meet the goal of extending current understanding of the causes of central nervous system disorders, thereby contributing to improvements in clinical outcomes and reducing the associated societal burden. The Anxiety Disorders Research Network (ADRN) has been adopted within the ECNP-NI: this consensus statement summarises its overall aims and objectives.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Anxiety Agents / therapeutic use
  • Anxiety Disorders / complications
  • Anxiety Disorders / diagnosis
  • Anxiety Disorders / economics
  • Anxiety Disorders / epidemiology
  • Anxiety Disorders / therapy*
  • Comorbidity
  • Consensus
  • Cost of Illness
  • Culture
  • Europe / epidemiology
  • Humans
  • Multicenter Studies as Topic
  • Public Health
  • Research
  • Research Support as Topic
  • Treatment Failure


  • Anti-Anxiety Agents